Since ICAM-1 is a general adhesion molecule and may be recognized by other T cell subtypes, such as αβ T cells, it is possible that a similar ICAM-1-dependent mechanism may be involved in the interaction between cancer and αβ T cells in an MHC-restricted manner. Here, ICAM1 is linked to cancer.